Therapeutic efficacy of Tyro3, Axl, and Mer tyrosine kinase agonists in collagen‐induced arthritis
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Objective: Hyperactivation of innate immunity by Toll‐like receptors (TLRs) can contribute to the development of autoinflammatory or autoimmune diseases. This study evaluated the activation of Tyro3, Axl, Mer (TAM) receptors, physiologic negative regulators of TLRs, by their agonists, growth arrest–specific protein 6 (GAS‐6) and protein S, in the prevention of collagen‐induced arthritis (CIA). Methods: Adenoviruses overexpressing GAS‐6 and protein S were injected intravenously or intraarticularly into mice during CIA. Splenic T helper cell subsets from intravenously injected mice were studied by flow cytometry, and the knee joints of mice injected intravenously and intraarticularly were assessed histologically. Synovium from mice injected intraarticularly was evaluated for cytokine and suppressor of cytokine signaling (SOCS) expression. Results: Protein S significantly reduced ankle joint swelling when overexpressed systemically. Further analysis of knee joints revealed a moderate reduction in pathologic changes in the joint and a significant reduction in the number of splenic Th1 cells when protein S was overexpressed systemically. Local overexpression of GAS‐6 decreased joint inflammation and joint pathology. Protein S treatment showed a similar trend of protection. Consistently, GAS‐6 and protein S reduced cytokine production in the synovium. Moreover, levels of messenger RNA for interleukin‐12 (IL‐12) and IL‐23 were reduced by GAS‐6 and protein S treatment, with a corresponding decrease in the production of interferon‐γ and IL‐17. TAM ligand overexpression was associated with an increase in SOCS‐3 levels, which likely contributed to the amelioration of arthritis. Conclusion: This study provides the first evidence that TAM receptor stimulation by GAS‐6 and protein S can be used to ameliorate arthritis when applied systemically or locally. TAM receptor stimulation limits proinflammatory signaling and adaptive immunity. This pathway provides a novel strategy by which to combat rheumatoid arthritis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SOCS proteins, cytokine signalling and immune regulation
Yoshimura, A., Naka, T., & Kubo, M. (2007) · Nature Reviews Immunology · doi:10.1038/nri2093 · Cited by 1,580 · cited 2×
“SOCS-1 blocks intracellular signaling, since SOCS-1 can directly inhibit myeloid differentiation factor 88 adaptor–like protein [Mal], an adapter molecule for TLR-2 and TLR-4 (7).”
Phagocytosis and clearance of apoptotic cells is mediated by MER
Scott, R. S., McMahon, E. J., Pop, S. M., Reap, E. A., Caricchio, R., Cohen, P. L., Earp, H. S., & Matsushima, G. K. (2001) · Nature · doi:10.1038/35075603 · Cited by 1,215 · cited 1×
“Mer is predominantly involved in phagocytosis (26) and plays a role in inflammation as well.”
TAM Receptors Are Pleiotropic Inhibitors of the Innate Immune Response
Rothlin, C. V., Ghosh, S., Zuniga, E. I., Oldstone, M. B. A., & Lemke, G. (2007) · Cell · doi:10.1016/j.cell.2007.10.034 · Cited by 1,055 · cited 10×
“Stimulation of cells via the Axl receptor in conjunction with interferon- / receptor (IFNAR) leads to up-regulation of suppressor of cytokine signaling (SOCS) proteins 1 and 3 (5,6), which are inhibitors of inflammation.”
InfluentialSelf-citationAbdollahi-Roodsaz, S., Joosten, L. A. B., Koenders, M. I., Devesa, I., Roelofs, M. F., Radstake, T. R. D. J., Heuvelmans-Jacobs, M., Akira, S., Nicklin, M. J. H., Ribeiro-Dias, F., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32639 · Cited by 527 · cited 1×
“TLRs have also been implicated in maintenance of the chronic inflammatory loop in RA synovium (8,9), and TLR-2 and TLR-4 play an important role in arthritis (10,11).”
Self-citationCamenisch, T. D., Koller, B. H., Earp, H. S., & Matsushima, G. K. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3498 · Cited by 290 · cited 1×
“It has been shown that Mer downregulates TNF production upon LPS stimulation (27) and is also involved in LPS-induced lung injury (6).”
Babon, J. J., McManus, E. J., Yao, S., DeSouza, D. P., Mielke, L. A., Sprigg, N. S., Willson, T. A., Hilton, D. J., Nicola, N. A., Baca, M., et al. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.024 · Cited by 163 · cited 1×
“In addition, cytokine signaling has been suggested to prevent SOCS-3 turnover (24).”
Sachithanandan, N., Graham, K. L., Galic, S., Honeyman, J. E., Fynch, S. L., Hewitt, K. A., Steinberg, G. R., & Kay, T. W. (2011) · Diabetes · doi:10.2337/db11-0259 · Cited by 81
Cited by
Apoptotic cell clearance: basic biology and therapeutic potential
Poon, I. K. H., Lucas, C. D., Rossi, A. G., & Ravichandran, K. S. (2014) · Nature Reviews Immunology · doi:10.1038/nri3607 · Cited by 1,223
Lemke, G. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009076 · Cited by 598
TAM Receptor Signaling in Immune Homeostasis
Rothlin, C. V., Carrera-Silva, E. A., Bosurgi, L., & Ghosh, S. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112103 · Cited by 510
Self-citationDiversification of TAM receptor tyrosine kinase function
Zagórska, A., Través, P. G., Lew, E. D., Dransfield, I., & Lemke, G. (2014) · Nature Immunology · doi:10.1038/ni.2986 · Cited by 430
Wu, H., Zheng, J., Xu, S., Fang, Y., Wu, Y., Zeng, J., Shao, A., Shi, L., Lu, J., Mei, S., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02041-7 · Cited by 344
Metadata
- Authors
- van den Brand, B. T., Abdollahi‐Roodsaz, S., Vermeij, E. A., Bennink, M. B., Arntz, O. J., Rothlin, C. V., van den Berg, W. B., & van de Loo, F. A. J.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2013-02-25
- Volume
- 65
- Issue
- 3
- Pages
- 671-680
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2037655090
- Cited by
- 77
- References
- 7
- FWCI
- 3.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.